1252P Update results of anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase Ⅱ clinical trial

Autor:	Y-F. Zhang, X-B. Li, Y-G. Hong, X-M. Li, W-M. Liang, Z-X. Zheng, G-Y. Yang, Y-Y. Wen, H. Cao, W-L. Wu, W-Z. Su
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S1120
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2f96efd43191d748dd69bd1ac001b1c9 https://doi.org/10.1016/j.annonc.2022.07.1370 Zobrazit plný text záznamu